J. Goldman & Co’s Q32 Bio QTTB Stock Holding History

J. Goldman & Co’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,389	Closed	-$559K	–	344
2018 Q4	$559K	Sell	1,389 -389	-22%	-$147K	0.04%	201
2018 Q3	$732K	Sell	1,778 -9,207	-84%	-$3.13M	0.05%	204
2018 Q2	$4.03M	Sell	10,985 -4,127	-27%	-$1.48M	0.21%	150
2018 Q1	$5.09M	Buy	+15,112	New	+$5.08M	0.22%	123

Other funds holding QTTB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VV Manager Boston, Massachusetts $114M AUM 59.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

J. Goldman & Co's QTTB Position: Q1 2019 in Review

J. Goldman & Co sold out of Q32 Bio (QTTB) in Q1 2019, closing a stake of 1,389 shares — an estimated $559K sold.

J. Goldman & Co first reported a position in QTTB in Q1 2018 and held it in 4 quarters. The position peaked at $5.09M in Q1 2018. 66 funds tracked by Wall St. Rank hold QTTB as of Q1 2019.

J. Goldman & Co reported no remaining Q32 Bio position as of Q1 2019 after selling out during the quarter.
J. Goldman & Co sold 1,389 Q32 Bio shares in Q1 2019, an estimated $559K.
J. Goldman & Co first reported a position in Q32 Bio in Q1 2018 and held it in 4 quarters.
J. Goldman & Co's Q32 Bio position peaked at $5.09M in Q1 2018.
66 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2019.

Based on J. Goldman & Co's 13F filing for Q1 2019, filed 14 May 2019.